Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 153 Lymphoid 136 Myeloid 5 Sarcoma 3 Tumor-Agnostic 2 CNS 2 Other 1 Gynecologic 1 Classical hematology 1 Breast 1

Conditions

Ovarian Neoplasms 1 Breast Neoplasms 1

Interventions

Trastuzumab 692 Paclitaxel 678 Cyclophosphamide 634 Docetaxel 553 Capecitabine 467 Letrozole 407 Carboplatin 392 Fulvestrant 377 Doxorubicin 330 Tamoxifen 288 pembrolizumab 270 Anastrozole 252 Epirubicin 249 exemestane 238 pertuzumab 226 Bevacizumab 214 Radiotherapy 213 Gemcitabine 211 Vinorelbine 188 palbociclib 183 Lapatinib 175 130-nm albumin-bound paclitaxel 168 Albumin-Bound Paclitaxel 156 Exercise 147 Magnetic Resonance Spectroscopy 145 eribulin 144 Taxes 134 Fluorouracil 131 Everolimus 118 Cisplatin 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mercaptopurine × Breast × Clear all

NCT01432145 2019-07-09

6MP

University of Oxford

Phase 2 Completed

74 enrolled 13 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡